Skip to content

英诺之家控股

US · INNV #3115 按市值排名 上市于 2021
8.85 -0.13 -1.45%
实时 - 追踪5344个代码 - 心跳于274秒前 · 2026-10-16 19:30

估值 各估值倍数与自身5年区间的对比

市净率 5.21 高于历史水平 第94百分位
5年平均 2.88 · 在Medical Care Facilities中排名第31/40
市盈率 -450.00 低于历史水平 第1百分位
5年平均 7.39 · 前瞻 20.34
市销率 1.24 高于历史水平 第73百分位
5年平均 1.06 · 前瞻 1.14 · 在Medical Care Facilities中排名第33/50

同业对比 Medical Care Facilities

公司 市值 市盈率(TTM) 市净率 股息率
英诺之家控股 (INNV) 1.21B -442.50 5.12 0.00%
HCA Healthcare (HCA) 99.34B 15.39 -14.96 0.65%
Tenet Healthcare (THC) 21.52B 10.33 4.62 0.00%
Encompass Health (EHC) 12.61B 20.83 4.86 0.59%
DaVita (DVA) 11.95B 15.44 -15.62 0.00%
Fresenius Medical Care (FMS) 11.80B 11.90 0.84 3.85%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值7.61 经济护城河None 不确定性High

当前股价高于晨星合理价值估算14.0%。

合理价值

InnovAge Holding Corp receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 18% premium over our quantitative fair value estimate of $7.61 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's valuation metrics decrease our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 19.3%, which sits in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are overvalued.

The firm's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 0.4%, for example, lies in the bottom 30% globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

经济护城河

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

英诺之家控股 讨论区 0 条评论

发表评论